We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Shorter MRI Exam Effectively Detects Cancer in Dense Breasts

By HospiMedica International staff writers
Posted on 03 Jun 2025

Women with extremely dense breasts face a higher risk of missed breast cancer diagnoses, as dense glandular and fibrous tissue can obscure tumors on mammograms. More...

While breast MRI is recommended for supplemental screening due to its higher accuracy, the lengthy procedure time and associated costs have limited its broader use. A new study now shows that abbreviated breast MRI significantly shortens exam time while retaining a high level of diagnostic accuracy, offering a faster, more accessible option for these high-risk patients.

The study by researchers at the University Medical Center at Utrecht University (Utrecht, Netherlandsl) builds on prior work from the Netherlands-based Dense Tissue and Early Breast Neoplasm Screening (DENSE) Trial, which investigated breast cancer screening in women with extremely dense breast tissue. In the latest study, the researchers performed a secondary analysis of a subset of MRI exams from the DENSE Trial to evaluate how much of the standard MRI protocol could be reduced without sacrificing diagnostic accuracy. Abbreviated MRI protocols reduce the typical 30–35 minute exam time of full-protocol breast MRI to as little as 10 minutes. This faster technique involves fewer imaging sequences while still allowing radiologists to assess the breast tissue for signs of cancer.

Seven experienced radiologists, each with at least 16 years of practice, read the same breast MRI exams with four sequences added one at a time, resulting in a total of 2,072 reads. After each step, the radiologists assigned Breast Imaging Reporting and Data System (BI-RADS) scores to determine whether a patient needed to be recalled for further testing. The study revealed that the abbreviated protocol offered sensitivity and specificity comparable to the full-protocol MRI. Importantly, adding more imaging sequences did not improve the radiologists’ ability to decide on recalls, confirming that the abbreviated protocol was sufficient. The findings, published in Radiology, demonstrated a dramatic reduction in both scan and reading times. The shortest scan time clocked in at under five minutes, with overall scan times reduced by up to 80% and reading times by 50%. This efficiency could allow more women to be screened in less time and improve the feasibility of incorporating breast MRI into national screening programs.

“Compared to mammography, breast MRI, whether abbreviated or full protocol, has a higher diagnostic accuracy for women with extremely dense breasts,” said study author Wouter B. Veldhuis, M.D., Ph.D. “Reducing the examination time and noise levels potentially improves patient experience. Moreover, shorter reading and scan times may allow implementation of MRI in national screening programs making it available for all women with extremely dense breasts.”

Related Links:
UMC Utrecht


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.